Human T-cell lymphotropic virus type I (HTLV-I) is endemic in various parts of the world, including the southern coastal areas of Japan, the West Indies and, to a lesser degree, the southeastern region of the United States among people of African descent (Kalyanaraman et al., 1985; Blayney et al., 1983; Catovsky et al., 1982) . In Jamaica, an HTLV-I endemic area, between 50% and 70% of all nonHodgkin's lymphoma cases are HTLV-I seropositive (Blattner et al., 1983; Gibbs et al., 1987) . In Trinidad/Tobago, HTLV-I infection is restricted largely to persons of African ancestry despite the fact that the population is equally divided between persons of Asian and African origin supporting the concept that the virus is endemic in Africa (Bartholomew et al., 1985) . This hypothesis was supported by our previous case report of a Nigerian with classical adult T-cell leukaemia/lymphoma (Williams et al., 1984) and recent population surveys of HTLV-I in various locales of Africa (Fleming et al., 1982; Saxinger et al., 1984; Fleming et al., 1986; Williams et al., 1987) . While the validity of the early HTLV-I serology in Africa has been questioned (Weiss et al., 1986) especially because of the remarkable discrepancy between the enzyme-linked screening and confirmatory assays when compared with the more sensitive Western immunoblot assay (Constantine et al., 1988; CDC, MMWR, 1988) . Confirmatory Western blot testing was performed using an investigational Western blot assay incorporating the recombinant transmembrane gene product p2le into standard whole virus (Biotech, Inc) (Liliehoj et al., 1989) . The seropositivity rates were computed as the product of the probabilities of positive outcome of the two tests. The 95% confidence intervals were computed from these characteristics using a standard statistical methodology. (Gibbs et al., 1987) .
Results
In 
Discussion
The case series reported here confirms previous reports of a strong correlation of HTLV-I to non-Hodgkin's lymphoma patients with features of adult T-cell leukaemia as originally 
ABD: adult blood donor; NSC: normal school children. BL-R: Burkitt's lymphoma studied in remission. Other abbreviations are explained in text. aPresumed to be twin sisters.
described in Japan and subsequently reported in residents of Jamaica, Trinidad and other locales in Caribbean as well as among West Indian immigrants to the United Kingdom and the US. The cases reported here while few in number confirm, along with our previous report of ATL in Ibadan, that HTLV-I and its associated lymphoma are documentable in Nigeria.
Although nine of our seropositive patients had typical B-cell lymphoproliferative disorders (two of 21 CLL, and seven of 47 Burkitt's lymphoma patients), it is likely that these represent coincidental infection since rates of positivity were no different from those in blood donors. ATL constituted four of the 30 NH/NBL cases (13.3%) in this population, in sharp contrast to the 50 to 60% rate observed in the endemic areas of Jamaica and Japan. The low proportion of ATL among our NH/NBL cases could be due either to an increase of non-ATL NH/NBL or to a reduced prevalence of ATL in the study population. A similar situation has been reported by Delaporte et al. (1988 Delaporte et al. ( , 1989 in other parts of Africa and could occur for several reasons. Under ascertainment may result from the death of a patient before coming to medical attention, a factor compounded by the poor health services of the study area. Reduced recognition of ATL as a clinical entity could also be a factor. The clinical features of ATL in Nigeria differed from those described in other endemic areas. For example, the cases from Ibadan had a bulkiness of lymph node (Williams et al., 1987) and extranodal involvement that appears more pronounced than those of cases from Japan and Jamaica, but similar to the observations of Fleming et al. (1986) in another part of Nigeria. It is also possible that HTLV-I predisposes to high mortality early in life resulting in a loss to death of persons who otherwise would have developed ATL as adults, possibly through the causation of immunodeficiency as described in the HTLV-I associated paediatric syndrome of infective dermatitis (LeGrenade et al., 1990) .
Much of the controversy surrounding the prevalence of HTLV-I infection in Africa results from inadequancies of early assays for detecting true seropositivity. The recent availability of second generation assays such as the p2le enhanced HTLV-I Western blot provide a more reliable serologic marker for detecting HTLV-I infection. For the purpose of this study, we have interpreted the requirement for seropositivity as minimally involving reactivity to p24 and p2le, or with p24 and gp46. As shown in Table III we observed that the combination of p24 and p2le is more likely to be present than in p24 and gp46. This lack of sensitivity for detecting gp46 has been previously reported and likely reflects the relative paucity of gp46 antigen in whole virus Western blot transfers (Lilienhoj et al.,1989) . Furthermore, changing criteria for seropositivity and small numbers of tests in previous Nigerian surveys (e.g. Williams et al., 1987) have added to instability of estimates of true seroprevalence.
Compared to serologic surveys from Jamaica, employing identical methods of Western blot confirmation, the patterns of seroreactivity in the current study differed. Specifically the number and intensity of bands in samples in this study is weaker than those observed in the known HTLV-I endemic area of Jamaica. Furthermore, p19 bands were absent in a significant portion of samples, including 50% and 58.8% respectively of normal blood donors and patients whose Western blots profiles otherwise satisfied the criteria of seropositivity. This circumstance is reminiscent of our previous reports from Panama where ATL is infrequent compared to expected, based on background HTLV seroprevalence (Lairmore et al., 1990; Reeves et al., 1990) . This paradox was recently explained by studies which demonstrated the frequent occurrence of HTLV-II in the Panamanian population (Lairmore et al., 1990) where, as pointed out by Wiktor et al. (1990) , a hallmark of HTLV-II reactivity is a diminished or absent p19 band compared to p24. While some cases in this study had absent p19 reactivity reminiscent of the findings in Panama and among intravenous drug users, this reactivity is unlikely to result from HTLV-II since this pattern was only seen in those with the weakest banding patterns. Thus, the finding in the current study in Nigeria of a lower than expected occurrence of ATL and high rate of Western blot reactivity but with aberrant profile (i.e. weak reactivity and sparse banding) suggests the possibility that a mixutre of true HTLV-I positivity and cross reactivity with a related virus may explain this paradox. An HTLV-II-like virus which has been recently reported in West Africa could be a candidate (Delaporte et al., 1991) . Alternatively, sera from Africa have been notoriously difficult to reliably test because of high rates of positivity (Biggar et al., 1985) . Conditions of specimen collection, storage and transportation are unlikely to have contributed significantly to these difficulties. Ultimately, however, in this population there is a need to evaluate virus type by culture and PCR to determine the true nature of this reactivity.
